$143.93 arrow  Change: 1.86 %Chge: 1.31% Vol: 333,936
End Of Day Prices
High: 144.34 | Low: 142.3 | Open: 142.3 | Close: 143.93
52 Wk High: 144.34 | 52 Wk Low: 109.37 | Todays Pivot: 143.52
Sector: Healthcare and Pharmaceuticals add stock to watch list

Johnson & Johnson Company Profile

Johnson & Johnson (JNJ) is a large cap multinational corporation trading on NYSE, part of the health care sector. The company is divided into three major divisions: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson (JNJ) manages 250 operating companies and franchises in 60 countries and is the second largest manufacturer of health care products. This company owns the Tylenol, Band-Aid and Neutrogena brands. Employing 115,500 people, the largest

» Read More About Johnson & Johnson

JNJ Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Perkinelmer 31.42 green arrow 41,377
Bio Rad Labs 139.35 green arrow 7,234
St Jude Med 35.51 green arrow 225,880
Valeant Pharmaceuticals Intl I 198.43 green arrow 127,464
Nuvasive 66.61 red arrow 26,077
Merck 35.595 green arrow 746,320
United Therapeutics Del 69.17 green arrow 616,100
Steris 45.17 red arrow 22,458

Above is a small selection of related companies to Johnson & Johnson which compete alongside JNJ within the Healthcare and Pharmaceuticals sector. To see more related companies to JNJ, view our stock market today information page.

Online News For Johnson & Johnson

Johnson & Johnson (JNJ) Wins Major Court Victory In Talc Cancer Case

Last Tuesday, an appeals court in Missouri vacated a $72 million jury award in a case involving Jacqueline Fox, 62, of Birmingham, Ala., who died of ovarian cancer in 2015 and who had been using Johnson's baby powder for more than 20 years. In his opinion ...

Johnson & Johnson (JNJ) Closes 0.86% Up on the Day for October 23

Shares of Johnson & Johnson (JNJ) ended the trading day Monday at $143.62, representing a move of 0.86%, or $1.22 per share, on volume of 6.67 million shares. Johnson & Johnson is a holding company, which is engaged in the research and development ...

Johnson & Johnson (JNJ) Posts Earnings Results, Beats Estimates By $0.10 EPS

(PXLW) has risen 230.12% since October 18, 2016 and is uptrending. It has underperformed by 0.80% the S&P500. While looking at the Stock's Performance, Johnson & Johnson now shows a Weekly Performance of 5.15%, where Monthly Performance is 4%, Quarterly ...

Johnson & Johnson (JNJ) Stake Increased by Russell Investments Group Ltd.

Korea Investment CORP now owns 2,130,033 shares of the company's stock valued at $265,296,000 after purchasing an additional 596,134 shares during the last quarter. The First Commonwealth Financial Corp holds 10,121 shares with $1.34M value, up from 5,311 ...

Achillion Announces Presentation of Data From OMEGA-1 Phase 2b Trial With Odalasvir, AL-335, and Simeprevir (JNJ-4178) at the 2017 Liver Meeting

NEW HAVEN, Conn., Oct. 23, 2017 (GLOBE NEWSWIRE) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) reported today Phase 2b data on JNJ-4178, the triple combination consisting of odalasvir, AL-335, simeprevir, following presentations at the 2017 Liver ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Johnson & Johnson quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for JNJ to choose from. Visit here to build your stock quote widget »